TOXFINDER is strongly committed with the European Cosmetic and REACH regulation by actively seeking for the reduction of animals in toxicological screenings.
Our approach is based on the principle that the analysis and integration of multi endpoints in in vitro cell models could be employed to create highly predictive models of human toxicity.
We help our clients to quickly understand the safety profiles of new products allowing them to move about those with the lowest risk for toxicity and hence the highest probability of regulatory and commercial success to market.
|
|
|
PRODUCTS & SERVICES
TOXFINDER deploys already established in-vitro toxicological tests such as hepatic toxicity, cutaneous irritation, immunotoxicity, mitochondrial toxicity, phototoxicity and develops new non-animal predictive methodologies to offer to the cosmetic, pharmaceutical and chemistry industries. Our first proprietary product,SENSITIZER PREDICTOR, is an in vitro alternative test that identifies the sensitization potential of chemicals and cosmetic ingredients. Besides the ethical and legal advantages, our technology is more economic and less time consuming than the current animal tests and has been recently submitted to the European Center for Validation of Alternative Methods (ECVAM). TOXFINDER is also optimizing a complementary test that will allow the estimation of the potency of the identified sensitizers. Our product roadmap includes the development of a panel of nanotoxicity tests and the establishment of a model for respiratory toxicity evaluation.
|
|
TARGET MARKETS / CLIENTS
TOXFINDER, is focused on the development of non-animal predictive toxicity tests that will help Cosmetic, Toiletry, Chemical and Pharmaceutical Industries to meet the existing and forthcoming legislation. Our final clients are the cosmetic bio/pharmaceutical, chemical and nutraceutical companies.
|
